Biocrates Life Sciences

BiotechnologySeries CInnsbruck, Austriabiocrates.com

Latest round

Series C

Last raised

Oct 2009

Total raised

$14M

Investors

1

About Biocrates Life Sciences

Biocrates Life Sciences AG is a leading company in the field of diagnostic biomarker research.

Who invested in Biocrates Life Sciences

1 investor across 3 rounds

See all investors in Biocrates Life Sciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Oct 1, 2009

    Amount

    $3M

    Investors

    Locked

  2. Series B

    Jun 1, 2008

    Amount

    $4.7M

    Investors

    Locked

  3. Series A

    Jun 23, 2006

    Amount

    $6.4M

    Investors

    Locked

Questions about Biocrates Life Sciences

Who invested in Biocrates Life Sciences?

Biocrates Life Sciences has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Biocrates Life Sciences raised?

Biocrates Life Sciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Biocrates Life Sciences last raise money?

Biocrates Life Sciences's most recent round on record is a Series C, in Oct 2009.

What does Biocrates Life Sciences do?

Biocrates Life Sciences AG is a leading company in the field of diagnostic biomarker research.

Where is Biocrates Life Sciences headquartered?

Biocrates Life Sciences is headquartered in Innsbruck, Austria.

Which VCs invest in companies like Biocrates Life Sciences?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Biocrates Life Sciences's stage. Their profiles are linked below.

Raising like Biocrates Life Sciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.